N
Neurode
Drug free, non-invasive treatment of ADHD
About Neurode
Neurode Labs operates in the cutting-edge field of brain-computer interfaces (BCIs), focusing on enhancing cognitive function and emotional well-being. The company serves a diverse range of clients, including individuals seeking cognitive enhancement, healthcare providers, and research institutions. Neurode Labs operates in the health tech market, leveraging advanced algorithms and optical systems to develop its products. The business model is primarily B2C (business-to-consumer), selling its products directly to end-users through its website and other online platforms. Revenue is generated through the sale of its BCI devices and related software subscriptions. The company's innovative approach aims to provide non-invasive solutions that help users improve their mental health and cognitive abilities.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Sydney, Australia
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 65.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Neurology, Neuromodulation and Neurostimulation, Spinout, Tech for Patients, Brain Computer Interfaces
- Technology
- Hardware, Deep Tech, Mobile app, IoT InternetOfThings
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Neurode.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2025 | $10M | $40M | Undisclosed | ↗ |
| SEED✓Equity / VC | Sep 2024 | $3.5M | $14M | PsyMed Ventures · Khosla Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Neurode is 7.7K monthly website visits, down 48.7% over the last three months. Neurode's team declined 7.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
SOSV
Hax
CSIRO Kick-Start
Khosla Ventures
PsyMed Ventures
Other known investors2 additional known investors
University of New South Wales
Stoic Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neurode on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neurode’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







